MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction.

Circ Res

From the Divisions of Genetics and Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (Y.Y., H.-W.C., Y.Q., D.D., M.N., Y.-D.L., S.F., K.U., K.-I.S., R.L.).

Published: August 2015


Article Synopsis

  • Rodent hearts can almost fully regenerate after injury early in life, but this ability declines significantly after the first week postnatally.
  • The study investigates miR-34a's role in cardiac regeneration following myocardial infarction, finding that its levels increase with age and differ between neonatal and adult hearts.
  • miR-34a negatively impacts cardiomyocyte proliferation and recovery in neonatal hearts, while reducing its activity in adult hearts promotes better post-injury remodeling and recovery.

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Rationale: In response to injury, the rodent heart is capable of virtually full regeneration via cardiomyocyte proliferation early in life. This regenerative capacity, however, is diminished as early as 1 week postnatal and remains lost in adulthood. The mechanisms that dictate postinjury cardiomyocyte proliferation early in life remain unclear.

Objective: To delineate the role of miR-34a, a regulator of age-associated physiology, in regulating cardiac regeneration secondary to myocardial infarction (MI) in neonatal and adult mouse hearts.

Methods And Results: Cardiac injury was induced in neonatal and adult hearts through experimental MI via coronary ligation. Adult hearts demonstrated overt cardiac structural and functional remodeling, whereas neonatal hearts maintained full regenerative capacity and cardiomyocyte proliferation and recovered to normal levels within 1-week time. As early as 1 week postnatal, miR-34a expression was found to have increased and was maintained at high levels throughout the lifespan. Intriguingly, 7 days after MI, miR-34a levels further increased in the adult but not neonatal hearts. Delivery of a miR-34a mimic to neonatal hearts prohibited both cardiomyocyte proliferation and subsequent cardiac recovery post MI. Conversely, locked nucleic acid-based anti-miR-34a treatment diminished post-MI miR-34a upregulation in adult hearts and significantly improved post-MI remodeling. In isolated cardiomyocytes, we found that miR-34a directly regulated cell cycle activity and death via modulation of its targets, including Bcl2, Cyclin D1, and Sirt1.

Conclusions: miR-34a is a critical regulator of cardiac repair and regeneration post MI in neonatal hearts. Modulation of miR-34a may be harnessed for cardiac repair in adult myocardium.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769861PMC
http://dx.doi.org/10.1161/CIRCRESAHA.117.305962DOI Listing

Publication Analysis

Top Keywords

cardiomyocyte proliferation
16
neonatal hearts
16
cardiac repair
12
adult hearts
12
repair regeneration
8
myocardial infarction
8
proliferation early
8
early life
8
regenerative capacity
8
early week
8

Similar Publications

Objectives: To investigate the effect of cardiomyocytes-derived exosomes on lipopolysaccharide (LPS)-induced cardiomyocyte injury and its mechanism.

Methods: Exosomes isolated from rat cardiomyocytes with or without LPS treatment were co-cultured with rat lymphocytes. The lymphocytes with or without exosome treatment were co-cultured with LPS-induced rat cardiomyocytes for 48 h.

View Article and Find Full Text PDF

Fludioxonil, a fungicide commonly used in agriculture, has been detected in livestock, such as cattle, even though it is primarily intended for use in plants. Unintended exposure to fludioxonil may compromise immune cells, cardiomyocytes, and glioma cells, indicating its potential risk as an environmental hazard. However, research on the detrimental effects of fludioxonil remains scarce, particularly regarding its impact on livestock, which are directly exposed to fludioxonil because of its widespread agricultural use.

View Article and Find Full Text PDF

Heart failure (HF) is a leading cause of death worldwide and the associated mortality and socioeconomic burden is predicted to worsen. Current therapies for HF focus on managing the causes and symptoms; however, these current treatment options are unable to reverse heart muscle degeneration, with heart transplantation the only cure. The ability to re-muscularise the heart represents a significant unmet clinical need.

View Article and Find Full Text PDF

The advancement of regenerative medicine requires robust, reproducible, and scalable platforms for the expansion and differentiation of human pluripotent stem cells (hPSCs) into specialized cells, such as cardiomyocytes. While current natural matrices like Matrigel™ suffer from batch-to-batch variability and limited tunability, synthetic scaffolds with controllable biochemical and mechanical properties could provide superior platforms for maintaining stem cell pluripotency and directing efficient cardiac differentiation. Here, we report the development and evaluation of a customizable thermoresponsive terpolymer composed of -isopropylacrylamide (NiPAAm), vinylphenylboronic acid (VPBA), and polyethylene glycol monomethyl ether monomethacrylate (PEGMMA) synthesized free-radical polymerization as a synthetic matrix for human hPSC culture.

View Article and Find Full Text PDF

MYCN Regulates Cardiomyocyte Proliferation, Metabolism, and Regeneration in the Mammalian Heart.

Circulation

September 2025

Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN (S.D., T.A.L., J.E.S.-P., X.M., Q.L., K.H., R.J.L., T.A., W.G., M.G.G., D.J.G.).

View Article and Find Full Text PDF